CPEB1 and osteosarcoma: Wang et al. reported that miRNA-320a inhibited cell growth ability, migration, and invasion by targeting the 3′-UTR of cytoplasmic polyadenylation element-binding protein 1 (CPEB1) in osteosarcoma, which might as a potential therapy target for osteosarcoma (11).